RightFit
Not yet recruitingNot applicable

Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
21 Years to 100 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests a web-based care program for people with advanced cancer and their spouse or live-in partner. It aims to reduce patients’ depression, pain, and tiredness and improve their quality of life. For caregivers, it aims to reduce stress, depression, and risk factors for heart and blood vessel disease.

To test the efficacy of a web-based stepped collaborative care intervention to reduce symptoms of depression, pain, and fatigue and improve health-related quality of life (HRQL) in advanced cancer patients and to reduce stress and depression, and fewer CVD risk factors in caregivers.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Patients: Have liver cancer, bile duct cancer, gallbladder cancer, or breast, ovarian, or colorectal cancer that has spread to the liver.
  • Patients: Cancer must be confirmed by a tissue sample or imaging test.
  • Patients: Be expected to live at least one year.
  • Patients: Be older than 21.
  • Patients: Have no signs or reports of disordered thinking, false beliefs, or current thoughts of suicide.
  • Caregivers: Be the spouse or live-in romantic partner of a person with advanced cancer being evaluated at UPMC’s Liver Cancer Center.
  • Caregivers: Be older than 21.

Who can't join

  • Patients and caregivers: Be younger than 21.
  • Patients and caregivers: Not be fluent in English.
  • Patients and caregivers: Have disordered thinking, false beliefs, see or hear things that are not there, or have thoughts of suicide.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Patients: Biopsy and/or radiograph proven diagnosis of hepatocellular carcinoma, cholangiocarcinoma, gallbladder carcinoma or breast, ovarian, or colorectal cancer with liver metastases with a life expectancy of at least one year; age \>21 years; no evidence of thought disorder, delusions, or active suicidal ideation is observed or reported. * Caregivers: A spouse or cohabitating intimate partner of an advanced cancer patient being evaluated the UPMC's Liver Cancer Center and age \>21 years Exclusion Criteria: * Patients: Age \< 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation. * Caregivers: Age \< 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation.

Study sites (2)

PA